Kanghong Pharmaceutical: Wholly-owned subsidiary absorb merger.

Kanghong Pharmaceutical announced that its wholly-owned subsidiary, Beijing Kanghong Biopharmaceutical Co., Ltd., plans to absorb and merge Beijing Hongjian Medical Devices Co., Ltd. and Sichuan Kanghong Chinese Medicinal Materials Planting Co., Ltd., and plans to absorb and merge Chengdu Kanghong Pharmaceutical Trading Co., Ltd. and Sichuan Jishengtang Pharmaceutical Co., Ltd., and plans to absorb and merge Sichuan Jishengtang Xingshang Biotechnology Co., Ltd. After the absorption and merger, Beijing Kanghong Biopharmaceutical, Kanghong Planting, and Jishengtang will continue to operate, with the company name and equity structure remaining unchanged. Beijing Hongjian, Chengdu Kangmao, and Xingshang Biotech will be deregistered in accordance with the law, and all of their assets, liabilities, businesses, personnel, related qualifications, and all other rights and obligations will be legally inherited by Beijing Kanghong Biopharmaceutical, Kanghong Planting, and Jishengtang respectively.